Specifically, ATG5 concentrations resulted in being significantly decreased in the temporal cortex of DLB and FTD patients, showing only a downward trend in the AD group, and in the frontal cortex specimens of all patients, with heterogenous values in AD patients. This evidence concerns the gene ATG5 and Lewy body dementia.